"I hope many readers have taken the opportunity to learn from the evolving science and gone back to review the basics of virology, immune response, and clinical trial development to gain a better understanding of this global pathogen," writes Raoul S. Concepcion, MD, FACS.
Case study of a patient with muscle-invasive bladder cancer.
A nurse practitioner discusses how she supports multiple providers in a large academic practice.
Providers must carefully consider treatment options to align with patient preference.
An expert panel discusses the case of a 65-year-old Caucasian male who is noted to have an incidental 3-cm right renal mass, enhancing on a contrasted CT scan as part of a routine follow-up for his metastatic castration-resistant prostate cancer, diagnosed in 2017 and currently undergoing therapy.
Opportunity exists to develop superior risk assessment models in prostate cancer.
